Assignee
ALECTOR LLC
US·48 granted patents·56 pending applications·97 citations·filing 2015–2025
Top patents by PatentIndex Score
104 records- 0196US11186645B2Isolated nucleic acids encoding anti-sortilin antibodiesALECTOR LLC·Filed 2020·Granted Nov 30, 2021·4 cites·48 claims
- 0296US10676525B2Anti-TREM2 antibodies and methods of use thereofALECTOR LLC·Filed 2018·Granted Jun 9, 2020·13 cites·60 claims
- 0394US10087255B2Anti-sortilin antibodies and methods of use thereofALECTOR LLC·Filed 2016·Granted Oct 2, 2018·12 cites·17 claims
- 0493US11208488B2Methods of increasing progranulin levels using anti-Sortilin antibodiesALECTOR LLC·Filed 2018·Granted Dec 28, 2021·4 cites·44 claims
- 0593US10849992B1Methods of screening for sortilin binding antagonistsALECTOR LLC·Filed 2016·Granted Dec 1, 2020·6 cites·8 claims
- 0693US10711062B2Anti-CD33 antibodies and methods of use thereofALECTOR LLC·Filed 2018·Granted Jul 14, 2020·7 cites·77 claims
- 0791US11084875B2Anti-TREM2 antibodies and methods of use thereofALECTOR LLC·Filed 2019·Granted Aug 10, 2021·4 cites·26 claims
- 0891US10428150B2Anti-sortilin antibodies and methods of use thereofALECTOR LLC·Filed 2018·Granted Oct 1, 2019·6 cites·17 claims
- 0991US2025092144A1Methods of use of anti-sortilin antibodies for treating a disease, disorder, or injuryALECTOR LLC·Filed 2024·Application pending·0 cites
- 1090US11965023B2Anti-Siglec-5 antibodies and methods of use thereofALECTOR LLC·Filed 2022·Granted Apr 23, 2024·1 cites·32 claims
- 1190US11634489B2Anti-TREM2 antibodies and methods of use thereofALECTOR LLC·Filed 2020·Granted Apr 25, 2023·2 cites·32 claims
- 1290US11254743B2Anti-CD33 antibodies and methods of use thereofALECTOR LLC·Filed 2020·Granted Feb 22, 2022·2 cites·20 claims
- 1390US10308718B2Anti-sortilin antibodies and methods of use thereofALECTOR LLC·Filed 2018·Granted Jun 4, 2019·6 cites·21 claims
- 1489US11667699B2Anti-MS4A4A antibodies and methods of use thereofALECTOR LLC·Filed 2020·Granted Jun 6, 2023·3 cites·93 claims
- 1589US11339223B2Methods of use of anti-Sortilin antibodies for treating a disease, disorder, or injuryALECTOR LLC·Filed 2018·Granted May 24, 2022·2 cites·59 claims
- 1688US12258410B2Anti-SIRPα antibodies and methods of use thereofALECTOR LLC·Filed 2024·Granted Mar 25, 2025·0 cites·76 claims
- 1788US11396546B2Anti-Sortilin antibodies and methods of use thereofALECTOR LLC·Filed 2019·Granted Jul 26, 2022·2 cites·22 claims
- 1886US11472874B2Anti-MS4A4A antibodies and methods of use thereofALECTOR LLC·Filed 2019·Granted Oct 18, 2022·3 cites·29 claims
- 1986US10800844B2Anti-Siglec-9 antibodies and methods of use thereofALECTOR LLC·Filed 2016·Granted Oct 13, 2020·2 cites·23 claims
- 2085US11174313B2Anti-CD33 antibodies and methods of use thereofALECTOR LLC·Filed 2016·Granted Nov 16, 2021·3 cites·16 claims
- 2184US12226482B2Anti-SIRP-alpha antibodies and methods of use thereofALECTOR LLC·Filed 2023·Granted Feb 18, 2025·0 cites·19 claims
- 2283US11779642B2Anti-SIRP-alpha antibodies and methods of use thereofALECTOR LLC·Filed 2017·Granted Oct 10, 2023·1 cites·20 claims
- 2383US11136390B2Anti-CD33 antibodies and methods of use thereofALECTOR LLC·Filed 2016·Granted Oct 5, 2021·3 cites·26 claims
- 2482US11319373B2Anti-SIRPA antibodies and methods of use thereofALECTOR LLC·Filed 2019·Granted May 3, 2022·1 cites·83 claims
- 2582US10875919B2Chimeric receptors and methods of use thereofALECTOR LLC·Filed 2017·Granted Dec 29, 2020·1 cites·8 claims
- 2682US2025297016A1Anti-sortilin antibodies and methods of use thereofALECTOR LLC·Filed 2025·Application pending·0 cites
- 2781US11440957B2Anti-TMEM106B antibodies and methods of use thereofALECTOR LLC·Filed 2018·Granted Sep 13, 2022·1 cites·43 claims
- 2881US11390680B2Anti-Siglec-7 antibodies and methods of use thereofALECTOR LLC·Filed 2020·Granted Jul 19, 2022·1 cites·30 claims
- 2981US2025092131A1Anti-TREM1 Antibodies and Methods of Use ThereofALECTOR LLC·Filed 2024·Application pending·0 cites
- 3080US2024067723A1Anti-siglec-9 antibodies and methods of use thereofALECTOR LLC·Filed 2023·Application pending·0 cites
- 3179US12247073B2Anti-CD33 antibodies and methods of use thereofALECTOR LLC·Filed 2019·Granted Mar 11, 2025·1 cites·84 claims
- 3279US12110327B2Anti-TREM1 antibodies and methods of use thereofALECTOR LLC·Filed 2022·Granted Oct 8, 2024·0 cites·22 claims
- 3379US11976119B2Anti-SIRPa antibodies and methods of use thereofALECTOR LLC·Filed 2022·Granted May 7, 2024·0 cites·91 claims
- 3479US2022185899A1Methods of increasing progranulin levels using anti-sortilin antibodiesALECTOR LLC·Filed 2021·Application pending·0 cites
- 3579US2022185898A1Methods of use of anti-sortilin antibodies for treating a disease, disorder, or injuryALECTOR LLC·Filed 2021·Application pending·0 cites
- 3678US11359014B2Anti-siglec-5 antibodies and methods of use thereofALECTOR LLC·Filed 2018·Granted Jun 14, 2022·2 cites·25 claims
- 3778US10590198B2Anti-siglec-7 antibodies and methods of use thereofALECTOR LLC·Filed 2016·Granted Mar 17, 2020·2 cites·31 claims
- 3877US12358991B2Anti-Sortilin antibodies and methods of use thereofALECTOR LLC·Filed 2022·Granted Jul 15, 2025·0 cites·52 claims
- 3977US12297277B2Anti-sortilin antibodies and methods of use thereofALECTOR LLC·Filed 2022·Granted May 13, 2025·0 cites·53 claims
- 4077US11147249B2Siglec transgenic mice and methods of use thereofALECTOR LLC·Filed 2017·Granted Oct 19, 2021·1 cites·18 claims
- 4177US2025223365A1Methods of use of anti-sortilin antibodiesALECTOR LLC·Filed 2024·Application pending·0 cites
- 4276US2025026827A1Anti-SIRP-Beta1 Antibodies and Methods of Use ThereofALECTOR LLC·Filed 2024·Application pending·0 cites
- 4375US2023312712A1Anti-trem2 antibodies and methods of use thereofALECTOR LLC·Filed 2023·Application pending·0 cites
- 4475US2025179189A1Anti-SIRPa Antibodies and Methods of Use ThereofALECTOR LLC·Filed 2025·Application pending·0 cites
- 4575US2023107639A1Anti-trem2 antibodies and methods of use thereofALECTOR LLC·Filed 2022·Application pending·0 cites
- 4674US12331111B2Anti-MS4A4A antibodies and methods of use thereofALECTOR LLC·Filed 2022·Granted Jun 17, 2025·0 cites·24 claims
- 4774US12331112B2Anti-MS4A4A antibodies and methods of use thereofALECTOR LLC·Filed 2022·Granted Jun 17, 2025·0 cites·28 claims
- 4874US2024287204A1Anti-mertk antibodies and methods of use thereofALECTOR LLC·Filed 2023·Application pending·0 cites
- 4973US12258398B2Anti-Siglec-5 antibodies and methods of use thereofALECTOR LLC·Filed 2019·Granted Mar 25, 2025·1 cites·34 claims
- 5073US12004494B2Siglec transgenic mice and methods of use thereofALECTOR LLC·Filed 2021·Granted Jun 11, 2024·0 cites·22 claims
Showing the top 50 of 104 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →